All patients with AML over 60 years of age should not be offered early allogeneic stem cell transplantation. Blood Adv. 2021..
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biol Blood Marrow Transplant. 2016.
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.
Hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes. J Natl Compr Canc Netw. 2013;11(10):1227-33..
The Impact of Body Mass Index on the Outcome of Hematopoietic Stem Cell Transplantation in Adults. Biol Blood Marrow Transplant. 2018..
A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis. Oncotarget. 2015..